COVID-19 severity among patients with multiple sclerosis treated with cladribine: A systematic review and meta-analysis

BACKGROUND: The Coronavirus 19 pandemic has raised new relevant questions regarding the management of patients with multiple sclerosis (pwMS) treated with different immunosuppressive and immunomodulant drugs. In most COVID-19 outcomes analyses, due to the small available sample size, patients treate...

Descripción completa

Detalles Bibliográficos
Autores principales: Albanese, Angela, Sormani, Maria Pia, Gattorno, Giovanni, Schiavetti, Irene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441479/
https://www.ncbi.nlm.nih.gov/pubmed/36137347
http://dx.doi.org/10.1016/j.msard.2022.104156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441479/
https://www.ncbi.nlm.nih.gov/pubmed/36137347
http://dx.doi.org/10.1016/j.msard.2022.104156

Ejemplares similares